Virtue Diagnostics nabs $100m in Series B round from Sequoia China, LAV, others

Virtue Diagnostics nabs $100m in Series B round from Sequoia China, LAV, others

06 January, 2022

Morningside Ventures Sequoia Capital China Virtue Diagnostics(Suzhou)

Printed by Unregistered user on Fri, 19 Dec 2025 23:09:26 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

China’s ABclonal bags $189m in Series D funding co-led by Sequoia Capital China

LAV, GL Ventures & China's Ruihua lead $156m round in CRO firm Tripod

Read more from Greater China

Chinese humanoid robot developer Galbot raises $300m at $3b valuation

‘Singapore washing’ gains pace as Chinese firms relocate to city-state